XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Jan. 28, 2023
Jan. 22, 2022
Cash flows from operating activities    
Net income $ 117,296 $ 94,706
Adjustments to reconcile net income to cash provided by operating activities    
(Gain)/loss on disposal and impairment of assets 6,161 (3,149)
(Gain)/loss on sale of investments 155 (340)
Provision for doubtful accounts 945 (1,070)
Depreciation and amortization 29,357 27,146
Amortization of right-of-use lease assets 57,548 53,949
Lease impairment 1,347 0
Equity-based compensation expense 8,456 8,887
Change in deferred taxes (2,629) 214
Change in receivables 42,474 (20,317)
Change in inventories 4,560 (83,109)
Change in other assets 16,478 (22,486)
Change in payables (10,624) 23,690
Change in lease liabilities (58,651) (54,400)
Change in other liabilities (85,821) 21,471
Net cash provided by operating activities 127,052 45,192
Cash flows from investing activities    
Proceeds from disposals of assets 121 3,999
Capital expenditures (57,439) (58,585)
Purchases of investments (6,970) (28,058)
Proceeds from sales of investments 18,178 30,457
Acquisitions (11,855) (24,849)
Net cash used for investing activities (57,965) (77,036)
Cash flows from financing activities    
Payments on debt and finance lease liabilities (92) (91)
Holdback payments for acquisition purchases (5,000) (23,000)
Stock issued for stock and employee benefit plans, net of shares withheld for taxes (1,771) (1,670)
Repurchases of common stock (5,004) (75,646)
Dividends paid to shareholders (22,027) (20,621)
Dividends paid to minority interest joint venture partners (1) [1] 0 (1,260)
Net cash used for financing activities (33,894) (122,288)
Effect of exchange rate changes on cash and equivalents (4) (593)
Change in cash, cash equivalents and restricted cash 35,189 (154,725)
Cash, cash equivalents and restricted cash at beginning of period 248,856 394,703
Cash, cash equivalents and restricted cash at end of period 284,045 239,978
Supplemental disclosure of non-cash investing activities    
Capital expenditures included in payables $ 2,828 $ 4,564
[1] Includes dividends paid to joint venture minority partners resulting from the repatriation of dividends from our foreign earnings that we no longer consider permanently reinvested.